A detailed history of Naples Global Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Naples Global Advisors, LLC holds 82,803 shares of BMY stock, worth $3.4 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
82,803
Previous 75,438 9.76%
Holding current value
$3.4 Million
Previous $3.87 Million 16.02%
% of portfolio
0.47%
Previous 0.43%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$47.98 - $54.4 $353,372 - $400,656
7,365 Added 9.76%
82,803 $4.49 Million
Q4 2023

Jan 11, 2024

BUY
$48.48 - $57.85 $460,026 - $548,938
9,489 Added 14.39%
75,438 $3.87 Million
Q3 2023

Oct 16, 2023

BUY
$57.89 - $64.73 $395,736 - $442,494
6,836 Added 11.56%
65,949 $3.83 Million
Q2 2023

Jul 17, 2023

BUY
$63.71 - $70.74 $203,107 - $225,519
3,188 Added 5.7%
59,113 $3.78 Million
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $144,102 - $163,444
2,193 Added 4.08%
55,925 $3.88 Million
Q4 2022

Jan 20, 2023

BUY
$68.48 - $81.09 $17,325 - $20,515
253 Added 0.47%
53,732 $0
Q3 2022

Oct 20, 2022

BUY
$0.13 - $76.84 $406 - $240,509
3,130 Added 6.22%
53,479 $3.8 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $49,308 - $54,306
679 Added 1.37%
50,349 $3.9 Million
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $140,358 - $168,302
2,283 Added 4.82%
49,670 $3.63 Million
Q4 2021

Feb 04, 2022

BUY
$53.63 - $62.52 $144,103 - $167,991
2,687 Added 6.01%
47,387 $2.96 Million
Q3 2021

Oct 25, 2021

BUY
$59.17 - $69.31 $424,663 - $497,437
7,177 Added 19.13%
44,700 $2.65 Million
Q2 2021

Aug 06, 2021

BUY
$61.91 - $67.42 $218,666 - $238,127
3,532 Added 10.39%
37,523 $2.51 Million
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $120,875 - $135,949
2,037 Added 6.37%
33,991 $2.15 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $20,555 - $23,293
356 Added 1.13%
31,954 $1.98 Million
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $94,587 - $104,815
1,647 Added 5.5%
31,598 $1.91 Million
Q2 2020

Aug 04, 2020

BUY
$54.82 - $64.09 $198,009 - $231,493
3,612 Added 13.71%
29,951 $1.76 Million
Q1 2020

Apr 27, 2020

BUY
$46.4 - $67.43 $10,393 - $15,104
224 Added 0.86%
26,339 $1.47 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $32,970 - $43,007
670 Added 2.63%
26,115 $1.68 Million
Q3 2019

Oct 28, 2019

BUY
$42.77 - $50.71 $51,366 - $60,902
1,201 Added 4.95%
25,445 $1.29 Million
Q2 2019

Jul 10, 2019

BUY
$44.62 - $49.34 $94,237 - $104,206
2,112 Added 9.54%
24,244 $1.1 Million
Q1 2019

Apr 29, 2019

BUY
$45.12 - $53.8 $46,699 - $55,683
1,035 Added 4.91%
22,132 $1.06 Million
Q4 2018

Feb 01, 2019

BUY
$48.76 - $63.23 $13,799 - $17,894
283 Added 1.36%
21,097 $1.01 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $35,487 - $40,026
643 Added 3.19%
20,814 $1.29 Million
Q2 2018

Jul 23, 2018

BUY
$50.53 - $62.98 $121,474 - $151,403
2,404 Added 13.53%
20,171 $1.12 Million
Q1 2018

Apr 17, 2018

BUY
$59.92 - $68.98 $5,932 - $6,829
99 Added 0.56%
17,767 $1.12 Million
Q4 2017

Jan 19, 2018

BUY
$59.94 - $65.35 $62,877 - $68,552
1,049 Added 6.31%
17,668 $1.08 Million
Q3 2017

Oct 16, 2017

BUY
$55.23 - $63.74 $917,867 - $1.06 Million
16,619
16,619 $1.06 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $87.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Naples Global Advisors, LLC Portfolio

Follow Naples Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Naples Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naples Global Advisors, LLC with notifications on news.